| Financial Year |
March 31 2022 |
| Monetary Funds |
96,687,462.41 |
| Held-for-trading Financial Assets |
443,376.21 |
| Notes Receivable |
136,859.60 |
| Accounts Receivable |
-- |
| Advances to Suppliers |
3,972,822.09 |
| Other Receivables |
588,867.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,286,628.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,475.90 |
| Total Current Assets |
112,883,702.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
2,854,486.56 |
| Fixed Assetes |
14,375,483.92 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,625,647.06 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
273,786.69 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
29,129,404.23 |
| Total Assets |
142,013,106.57 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
488,663.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,680,407.93 |
| Taxes Payable |
18,829,247.55 |
| Interest Payable |
-- |
| Dividend Payable |
983,649.69 |
| Other payables |
66,709,889.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
84,039.82 |
| Sub-Total of Current Liabilities |
122,376,390.68 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
-- |
| Total Liabilities |
122,376,390.68 |
| Paid-In Capital(Or Share Stock) |
148,107,148.00 |
| Capital Surplus |
307,252,322.29 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-453,597,937.26 |
| Minority Stockholder's Interest |
-1,527,515.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
21,164,231.00 |
| Owner's Equity（Stockholder's Equity） |
19,636,715.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
142,013,106.57 |
